Tag: European Union

Home / European Union

Categories

Tecartus granted European marketing authorization for treatment of relapsed or refractory acute lymphoblastic leukemia

Sept 2022: The European Commission (EC) has authorized Kite's CAR T-cell therapy Tecartus® (brexucabtagene autoleucel) for the treatment of adult patients 26 years of age and older with relapsed or r...
european-union

Scan the code